AMPH — AMPHASTAR PHARMACEUTICALS IN
Health Care
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying AMPH?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their AMPH position last quarter, 2 bought and 1 sold (67% buy-side). Macro conditions are a headwind for Health Care (Macro Tailwind 36/100 in a Expansion regime).
- +2 tracked investors added or increased positions last quarter (Paul Tudor Jones, Ken Griffin)
- +4 tracked investors reported holding AMPH at their latest filing
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −Current Expansion regime has historically been a headwind for Health Care (Macro Tailwind 36/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About AMPHASTAR PHARMACEUTICALS IN (AMPH)
AMPHASTAR PHARMACEUTICALS IN (AMPH) appears in the most recent 13F filings of 4 tracked institutional investors. AMPHASTAR PHARMACEUTICALS IN is classified in the Health Care sector. The largest disclosed position is held by Howard Marks (Oaktree Capital Management), valued at $40M. Across recent filings, tracked investors recorded 10 new positions, 5 increased, 10 reduced, and 6 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AMPH
How many top investors track AMPH
A small number of top investors own this.
AMPH Ownership Composition
How AMPHASTAR PHARMACEUTICALS IN is held across tracked investor types, based on reported 13F positions.
- Value & Distressed50.9%
- Multi-Strategy / Quant48.0%
- Macro1.1%
Tracked investors currently reporting AMPH
1 tracked investor has since exited this position — listed separately below.
- Howard MarksJun 30, 2026Oaktree Capital ManagementShares40.9MValue$37.2M% Portfolio0.52%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares34MValue$31.6M% Portfolio0.01%
- Ken GriffinSep 30, 2026Citadel AdvisorsShares132KValue$3.4M% Portfolio0.00%
- Paul Tudor JonesSep 30, 2026Tudor Investment CorpShares30.1KValue$775.7K% Portfolio0.00%
Previously held AMPH
These investors reported AMPH in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Steve Cohen | Point72 Asset Management | 55K | $1.1M | Jun 30, 2026 |
Recent activity
- $775.7KNov 16, 2026
- Unchanged$31.6M(0.00%)Nov 16, 2026
- Sold$0(-100.00%)Nov 16, 2026
- Increased$3.4M(250.83%)Nov 16, 2026
- Reduced$12.6M(-64.85%)Nov 14, 2024
- Reduced$9.5M(-1.19%)Feb 14, 2025
- Increased$25.2M(238.54%)May 15, 2025
- Reduced$14.2M(-28.73%)Aug 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- $31MAug 14, 2026
- New$16.2MNov 13, 2025
- Increased$40.4M(144.48%)Feb 17, 2026
- Reduced$34.5M(-12.72%)May 20, 2026
- Increased$37.2M(7.48%)Aug 14, 2026
- Reduced$7.9M(-40.59%)Nov 14, 2024
- Reduced$5.5M(-96.86%)May 15, 2025
- Increased$7.4M(71.43%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- New$759.4KAug 14, 2026
- Reduced$1.9M(-83.54%)Nov 14, 2024
- Reduced$341.6K(-76.30%)Feb 14, 2025
- Sold$0(-100.00%)Jul 21, 2025
- New$1.1MAug 14, 2026
- $777.1KAug 14, 2024
- Reduced$296.8K(-68.52%)Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $631.8KMay 15, 2025
- Reduced$296.6K(-40.73%)Aug 14, 2025
- Sold$0(-100.00%)Dec 9, 2025
- New$9.4MSep 16, 2024
- New$11MAug 14, 2024
- $17.6MMay 15, 2024
Frequently asked questions
- How many institutional investors hold AMPH?
- 4 tracked institutional investors disclosed a position in AMPH (AMPHASTAR PHARMACEUTICALS IN) in their most recent 13F filing.
- Who is the largest institutional holder of AMPH?
- Howard Marks, Oaktree Capital Management, holds the largest disclosed position in AMPH, valued at $40M.
- Did institutional ownership of AMPH increase or decrease?
- Across recent 13F filings, tracked investors recorded 10 new positions, 5 increased, 10 reduced, and 6 fully exited AMPH.
- What sector is AMPH in?
- AMPHASTAR PHARMACEUTICALS IN is classified in the Health Care GICS sector.
- Where does this AMPH ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.